Andreas Seidl

Chief Tech/Sci/R&D Officer at FORMYCON AG

Health Technology

Consumer Services

Health Services

Profile

Andreas Seidl currently works at Formycon AG, as Chief Scientific Officer from 2022.
Dr. Seidl also formerly worked at LEUKOCARE AG, as Chief Operating Officer from 2019 to 2022, Hexal Biotech GmbH, as Head-Analytics & Quality Control from 2002 to 2010, and Novartis AG, as Site Manager from 2010 to 2015.
Dr. Seidl received his doctorate degree from Universität Konstanz.

Andreas Seidl active positions

Companies	Position	Start
FORMYCON AG	Chief Tech/Sci/R&D Officer	30/06/2022

All active positions of Andreas Seidl

Former positions of Andreas Seidl

Companies	Position	End
LEUKOCARE AG LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions	Chief Operating Officer	31/12/2021
NOVARTIS AG	Corporate Officer/Principal	31/12/2014

See the detail of Andreas Seidl's experience

Training of Andreas Seidl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andreas Seidl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
Universität Konstanz Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LEUKOCARE AG LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions	Health Services
Formycon AG Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology